XML 93 R81.htm IDEA: XBRL DOCUMENT v3.22.2
Capital Stock and Reserves - Additional Information (Details)
$ / shares in Units, $ / shares in Units, ¥ in Millions, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 27, 2022
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2022
HKD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2022
HKD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
CNY (¥)
shares
Jun. 23, 2022
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2021
CNY (¥)
Jun. 11, 2020
shares
Jul. 01, 2017
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Share-based compensation costs recorded for the period   $ 7,600,000   $ 6,800,000 $ 13,700,000   $ 12,100,000              
Stock-based compensation expense   $ 7,637,000   $ 6,795,000 $ 13,689,000   $ 12,102,000              
Maximum number of shares of common stock may be issued for outstanding PSU | shares   56,095,372     56,095,372     58,653,642 58,653,642          
Common shares purchased in open market by trustee in connection with RSUs | shares   0 0 0 0 0 0              
Number of treasury shares held in trust for future settlement of share based awards | shares         0 0   0 0          
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares   6,302,818 6,302,818 6,239,713 6,302,818 6,302,818 6,239,713              
Percentage of statutory net profits to statutory surplus reserve to be appropriated   10.00%     10.00%                  
Discontinuation of contribution, Aggregate sum of statutory surplus reserve more than its registered capital,percent.   50.00%     50.00%                  
Statutory surplus reserve appropriated   $ 0     $ 0           $ 5,600,000 ¥ 36.4    
Dividends declared and paid               $ 20,400,000 ¥ 131.6          
Statutory surplus reserve to its subsidiaries registered capital percent                     50.00% 50.00%    
Subsequent Event [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Repurchase of common shares | shares 71,467                          
Stock Acquired, Average Cost per Share | $ / shares $ 15.93                          
Change in ownership interest related to IMAX China common share repurchases $ 1,100,000                          
IMAX China                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Details of the share repurchase program         In 2021, IMAX China's shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10% of the total number of issued shares as of May 6, 2021 (34,835,824 shares). This program expired on the date of the 2022 Annual General Meeting of IMAX China on June 23, 2022. During the 2022 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of June 23, 2022 (34,063,480 shares). This program will be valid until the 2023 Annual General Meeting of IMAX China. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time. In 2021, IMAX China's shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10% of the total number of issued shares as of May 6, 2021 (34,835,824 shares). This program expired on the date of the 2022 Annual General Meeting of IMAX China on June 23, 2022. During the 2022 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of June 23, 2022 (34,063,480 shares). This program will be valid until the 2023 Annual General Meeting of IMAX China. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time.                
Stock Repurchase Program Expiration Date         Jun. 23, 2022 Jun. 23, 2022 May 06, 2021              
Repurchase of common shares | shares   0 0 0 1,448,000 1,448,000 0              
Stock Acquired, Average Cost per Share | (per share)   $ 0 $ 0   $ 1.26 $ 9.89                
Change in ownership interest related to IMAX China common share repurchases   $ 0 $ 0.0   $ 1,800,000 $ 14.3                
Stock Repurchase Program, maximum percentage of shares to be repurchased                   10.00%     10.00%  
Stock Repurchase Program, Authorized number of shares | shares                   34,063,480     34,835,824  
Parent [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Details of the share repurchase program         April 28, 2022, the Company’s Board of Directors approved a 12-month extension to its share repurchase program through June 30, 2023. The extension authorized the Company to repurchase up to the remaining amount available of the original $200.0 million initially authorized under the share repurchase program when it commenced on July 1, 2017. The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant a plan intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time. April 28, 2022, the Company’s Board of Directors approved a 12-month extension to its share repurchase program through June 30, 2023. The extension authorized the Company to repurchase up to the remaining amount available of the original $200.0 million initially authorized under the share repurchase program when it commenced on July 1, 2017. The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant a plan intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.                
Stock Repurchase Program, Authorized Amount   $ 26,200,000     $ 26,200,000                 $ 200,000,000.0
Stock Repurchase Program Expiration Date         Jun. 30, 2023 Jun. 30, 2023                
Repurchase of common shares | shares   2,702,548 2,702,548   3,083,200 3,083,200                
Stock Acquired, Average Cost per Share | $ / shares   $ 15.92     $ 15.99                  
Change in ownership interest related to IMAX China common share repurchases   $ 43,000,000.0     $ 49,300,000                  
Statutory surplus reserve appropriated                     $ 3,900,000      
Non-controlling Interests [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Change in ownership interest related to IMAX China common share repurchases         1,301,000                  
Statutory surplus reserve appropriated                     $ 1,700,000      
Restricted Share Units [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock-based compensation expense   $ 4,478,000   $ 4,473,000 $ 7,889,000   $ 7,624,000              
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares   1,408,956 1,408,956 1,604,986 1,408,956 1,408,956 1,604,986              
Restricted Share Units [Member] | Non-Employee Directors [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock-based compensation expense   $ 1,300,000   $ 1,300,000 $ 1,300,000   $ 1,300,000              
Restricted Share Units [Member] | Non-Employee Directors [Member] | IMAX China                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock-based compensation expense       1,300,000     1,300,000              
Employee Stock Option [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock-based compensation expense   $ 122,000   $ 204,000 $ 329,000   $ 555,000              
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares   3,607,391 3,607,391 3,850,807 3,607,391 3,607,391 3,850,807              
Performance Stock Units [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock-based compensation expense   $ 1,724,000   $ 972,000 $ 3,453,000   $ 1,986,000              
Stock based awards vesting period         3 years 3 years                
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares   1,286,471 1,286,471 783,920 1,286,471 1,286,471 783,920              
Performance Stock Units [Member] | Minimum [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage         0.00% 0.00%                
Performance Stock Units [Member] | Maximum [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage         175.00% 175.00%                
Performance Stock Units [Member] | EBITDA | Maximum [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Maximum number of shares of common stock may be issued for outstanding PSU | shares   1,687,823     1,687,823